Skip to content

Effects of one leg-standing on cardiovascular function in humans

Effects of one leg-standing on cardiovascular function in humans

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082627
Enrollment
Unknown
Registered
2024-04-02
Start date
2024-04-02
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group 1:23 participants and experimental regimens were randomly divided, and each participant participated in three regimens: blank control regimen (CON), flat single-leg standing for 6 m
Experimental group 2:Randomly divide 22 participants and the experimental regimens, with each participant participating in 7 experimental regimens: blank regimen (CON), 3 min standing on the left side

Sponsors

Capital University of Physical Education and Sports
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years over; 2. The subject has no history of organ disease and drug allergy, no history of drug abuse, smoking or alcoholism; 3. Physical examination, laboratory examination, 12-lead electrocardiogram and vital signs examination were judged as healthy subjects by the researcher; 4. No prescription drugs, over-the-counter drugs, or proprietary Chinese medicines were used 2 weeks before the test.

Exclusion criteria

Exclusion criteria: 1. Smoking, alcohol abuse, excessive drinking of strong tea, coffee and caffeinated beverages during the 6 months before screening and during the trial; 2. History of prescription drug abuse and illegal drugs abuse within the 6 months before screening; 3. Subjects who are participating in other clinical trials; 4. Researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Cardio-ankle vascular index;

Secondary

MeasureTime frame
Heart rate variability;Surface electromyography;NO;ROS;SOD;MDA;TAC, total antioxidant capacity;GPX;endothelin-1;

Countries

China

Contacts

Public ContactWeili Zhu

Capital University of Physical Education and Sports

weili_zhu@163.com+86 10 8209 9063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026